25 completed, 1 withdrawn. 16 Phase 3, 5 Phase 2, 3 Phase 1, 2 Not applicable.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 16 | Completed 16 |
| Phase 2 | 5 | Completed 4, Withdrawn 1 |
| Phase 1 | 3 | Completed 3 |
| Not applicable | 2 | Completed 2 |
Follow Beclomethasone Dipropionate: new trials by email Literature Review of Beclomethasone Dipropionate trials Research Report on Beclomethasone Dipropionate
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study Testing the Superiority of CHF 1535 pMDI 800/24µg Total Daily Dose Compared With CHF 718 pMDI 800µg Total Daily Dose in Adults With Asthma on Medium or High-Dose Inhaled Corticosteroid Beclomethasone Dipropionate/Formoterol Fumarate, Beclomethasone Dipropionate - Asthma | Phase 3 | Completed | Chiesi Farmaceutici S.p.A. | 1377 | 2022-08-31 | 2026-07-20 |
| A Study Comparing Efficacy, Safety and Tolerability of the Fixed Dose Triple Combination CHF 5993 With the Fixed Dose Dual Combination CHF 1535 in Subjects With COPD Beclomethasone Dipropionate, Glycopyrronium Bromide, Formoterol Fumarate - COPD, COPD Exacerbation | Phase 3 | Completed | Chiesi Farmaceutici S.p.A. | 3406 | 2022-04-27 | 2026-09-21 |
| Evaluation of Systemic Bioavailability and Effects on 24-Hour Plasma Cortisol Profile of 6 mg Delivered Once Daily Versus 3 mg Delivered Twice Daily in Healthy Adult Male Volunteers Beclomethasone dipropionate - Healthy Adult Male Volunteers | Phase 1 | Completed | SOFAR S.p.A. | 28 | 2021-10-22 | 2022-05-04 |
| Front Line Ibrutinib Without Corticosteroids for Newly Diagnosed Chronic Graft-versus-Host Disease Ibrutinib, ECG, PFT's - Chronic GVHD | Phase 2 | Completed | National Cancer Institute (NCI) | 10 | 2021-05-10 | 2026-01-23 |
| Study of Fluticasone Propionate MDPI Compared With Fluticasone/Salmeterol MDPI in Adolescent and Adult Patients With Persistent Asthma FS MDPI, Fp MDPI, Placebo MDPI - Asthma | Phase 3 | Completed | Teva Branded Pharmaceutical Products R&D, Inc. | 787 | 2014-06-01 | 2021-11-12 |
| A Safety and Efficacy Study of Beclomethasone Dipropionate Delivered Via Breath-Actuated Inhaler (BAI) or Metered-Dose Inhaler (MDI) in Participants >=12 Years Old With Persistent Asthma Beclomethasone dipropionate, Placebo, Albuterol/salbutamol - Asthma | Phase 3 | Completed | Teva Branded Pharmaceutical Products R&D, Inc. | 1113 | 2013-12-01 | 2021-11-09 |
| Study of an Investigational Nasal Aerosol or Placebo in Children (Ages 4 to 11) With Perennial Allergic Rhinitis (PAR) BDP Nasal Aerosol, Placebo - Allergic Rhinitis | Phase 3 | Completed | Teva Branded Pharmaceutical Products R&D, Inc. | 547 | 2013-01-01 | 2015-10-12 |
| Hypothalamic-Pituitary-Adrenal (HPA)-Axis Study in Pediatric Subjects With Perennial Allergic Rhinitis (PAR) BDP, Placebo - Allergic Rhinitis | Phase 3 | Completed | Teva Branded Pharmaceutical Products R&D, Inc. | 99 | 2012-10-01 | 2015-10-08 |
| Hypothalamic-Pituitary-Adrenal (HPA) Axis Study in Adult and Adolescent Subjects With Perennial Allergic Rhinitis (PAR) Placebo Nasal Aerosol, Prednisone capsules, Placebo Prednisone Capsules - Perennial Allergic Rhinitis | Phase 3 | Completed | Teva Branded Pharmaceutical Products R&D, Inc. | 107 | 2010-06-01 | 2012-07-04 |
| Assessment of Oxidative Stress Markers in the Upper and Lower Airways of Atopic Children Treated With Nebulized Beclomethasone beclomethasone dipropionate, placebo - Asthma, Allergic Rhinitis | Phase 3 | Completed | Fondazione C.N.R./Regione Toscana "G. Monasterio", Pisa, Italy | 32 | 2010-04-01 | 2010-07-27 |
| A Randomized Double Blind Placebo Controlled Study of the Effect of Swallowed Beclomethasone Dipropionate on Inflammatory Markers in Adult Patients With Eosinophilic Esophagitis Beclomethasone dipropionate, placebo - Eosinophilic Esophagitis | Phase 1 | Completed | Penn State University | 20 | 2010-03-01 | 2012-11-30 |
| Study in Adult and Adolescent Subjects With Seasonal Allergic Rhinitis (SAR) Beclomethasone dipropionate, Placebo Nasal Aerosol - Seasonal Allergic Rhinitis, Hay Fever | Phase 3 | Completed | Teva Branded Pharmaceutical Products R&D, Inc. | 340 | 2009-12-31 | 2021-12-03 |
| Long Term Safety and Efficacy Trial of Beclomethasone Dipropionate - Hydrofluoroalkane (BDP-HFA) 320 mcg in Allergic Rhinitis Beclomethasone dipropionate, Placebo Nasal Aerosol - Rhinitis, Allergic, Perennial | Phase 3 | Completed | Teva Branded Pharmaceutical Products R&D, Inc. | 529 | 2009-10-31 | 2021-12-03 |
| Asthma Clinical Research Network (ACRN) Trial - Tiotropium Bromide as an Alternative to Increased Inhaled Corticosteroid in Patients Inadequately Controlled on a Lower Dose of Inhaled Corticosteroid (TALC) tiotropium bromide, salmeterol xinafoate, beclomethasone dipropionate - Asthma | Phase 3 | Completed | Milton S. Hershey Medical Center | 210 | 2008-05-01 | 2018-07-02 |
| Study of Asthma Phenotypes and Pharmacogenomic Interactions by Race-Ethnicity (SAPPHIRE) beclomethasone dipropionate - Asthma | Not applicable | Completed | Henry Ford Health System | 362 | 2007-10-01 | 2019-04-02 |
| Beclomethasone Dipropionate in Preventing Acute Graft-Versus-Host Disease in Patients Undergoing a Donor Stem Cell Transplant for Hematologic Cancer beclomethasone dipropionate, placebo, tacrolimus - Hematopoietic/Lymphoid Cancer, Accelerated Phase Chronic Myelogenous Leukemia | Phase 2 | Completed | Fred Hutchinson Cancer Center | 140 | 2007-04-01 | 2021-02-03 |
| (CARE Network Trial - Treating Children to Prevent Exacerbations of Asthma (TREXA) Beclomethasone dipropionate, Albuterol sulfate - Asthma | Phase 3 | Completed | Milton S. Hershey Medical Center | 288 | 2006-11-01 | 2018-07-02 |
| Validation Of Preference Module Of Experience With Allergic Rhinitis Nasal Sprays Questionnaire (EARNS-Q) Beclomethasone dipropionate, Flunisolide - Rhinitis, Allergic, Perennial | Phase 3 | Completed | GlaxoSmithKline | 97 | 2006-05-01 | 2018-01-16 |
| Efficacy and Safety of Nebulised Beclomethasone Dipropionate Plus as Needed Salbutamol vs as Needed Salbutamol or as Needed Salbutamol/Beclomethasone Fixed Combination in Young Children With Asthma Symptoms Beclomethasone dipropionate, Beclomethasone dipropionate/Salbutamol combination, Salbutamol - Bronchial Asthma | Phase 3 | Completed | Chiesi Farmaceutici S.p.A. | 283 | 2006-03-01 | 2020-08-03 |
| 7 Day Study of Mast Cell Inhibitor, R926112, in Patients With Symptomatic Seasonal Allergic Rhinitis R926112, Beclomethasone dipropionate - Rhinitis, Allergic, Seasonal | Phase 2 | Completed | Rigel Pharmaceuticals | 375 | 2005-07-01 | 2005-11-11 |
Showing 20 of 26. Sign in to see all of them.
Asthma (10) · Rhinitis, Allergic (6) · Graft vs Host Disease (4) · Rhinitis, Allergic, Seasonal (4) · Rhinitis, Allergic, Perennial (3) · Blast Crisis (2) · Burkitt Lymphoma (2) · Hematologic Neoplasms (2) · Hodgkin Disease (2) · Leukemia, Hairy Cell (2) · Leukemia, Lymphocytic, Chronic, B-Cell (2) · Leukemia, Myeloid, Accelerated Phase (2) · Leukemia, Myeloid, Acute (2) · Leukemia, Myeloid, Chronic-Phase (2) · Leukemia, Myelomonocytic, Chronic (2)
Teva Branded Pharmaceutical Products R&D, Inc. (8) · Chiesi Farmaceutici S.p.A. (3) · Fred Hutchinson Cancer Center (2) · Milton S. Hershey Medical Center (2) · Fondazione C.N.R./Regione Toscana "G. Monasterio", Pisa, Italy (1) · GlaxoSmithKline (1) · Henry Ford Health System (1) · Memorial Sloan Kettering Cancer Center (1) · National Cancer Institute (NCI) (1) · National Institute of Allergy and Infectious Diseases (NIAID) (1) · Penn State University (1) · Research in Real-Life Ltd (1) · Rigel Pharmaceuticals (1) · Roswell Park Cancer Institute (1) · SOFAR S.p.A. (1)
United States (21) · Poland (4) · Hungary (3) · Canada (2) · Czechia (2) · Italy (2) · Puerto Rico (2) · Ukraine (2) · Argentina (1) · Bulgaria (1) · Germany (1) · Mexico (1) · Romania (1) · Russia (1) · South Africa (1)
Alison Chisholm, MSc (1) · David Hockenbery, MD (1) · David Price, Prof. MD (1) · David T. Mauger, PhD (1) · Eli Meltzer, M.D. (1) · Elliot Israel, MD (1) · Elliott Grossbard, M.D. (1) · Emily A. DiMango, MD (1) · Fernando D. Martinez, MD (1) · Harold Nelson, M.D. (1) · Homer A. Boushey, MD (1) · J Zurlo (1)
PMID 36472162, PMID 19772514, PMID 20075384, PMID 20979471, PMID 21324520, PMID 21859484, PMID 22737708, PMID 23026180, PMID 23062389, PMID 24084072, PMID 24992552, PMID 26115578, PMID 26250771, PMID 27216137, PMID 27510595, PMID 28624608, PMID 28763243, PMID 30367910, PMID 36161875, PMID 37602534, PMID 41231513
2014 (1), 2023 (1), U10HL064287 (1), U10HL064288 (1), U10HL064295 (1), U10HL064305 (1), U10HL064307 (1), U10HL064313 (1), U10HL074073 (1), U10HL074204 (1), U10HL074206 (1), U10HL074208 (1), U10HL074212 (1), U10HL074218 (1), U10HL074225 (1)